chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Magnetic resonance imaging neck, Migraine, Pruritus, Rash
Clinical narrative: migraine; Rash,pretty bad,only on upper torso from sternum up,my back,neck,to base of my scalp to skull, kind of freaky; It's more like red and purple bluish blotches everywhere and they are itchy; they are itchy; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0171, Expiry date was not reported), via an unspecified route of administration on 30Apr2021 (at the age of 53-years-old) in Arm Left as dose 2, single for COVID-19 immunization. Medical history included coeliac disease from 2012 to an unknown date and stated, I have to avoid Wheat, rye and barley. There is no medicine there is no treatment. narcolepsy from an unknown date and unknown if ongoing. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for narcolepsy, start and stop date were not reported. Patient received other products. The patient reviously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot Number: EW0158 and Expiry date was not reported), via an unspecified route of administration on 09Apr2021 as dose 1, single for COVID-19 immunization. On 07May2021, she broke out in this rash and it's pretty bad and only on the upper torso from the sternum up mostly her back her neck and all the way to the base of her scalp to her skull and is kind of freaky but was not red like hives and it was not red like the pictures she saw online was more like red and purple bluish blotches everywhere and they are itchy and she have tried Benadryl but it does not work and So, she had read that this is a side effect and she think it needs to be reported and it was not going away. On unspecified date patient had migraine. The patient underwent lab tests and procedures which included she actually did just have a bunch of blood test done blood work done on 05May2021 because it was like on Monday this past Monday she had an MRI with contrast unknown results, Ultrasound of the Thyroid unknown results. Consumer stated, she dont know the Lab test yet but she do know she mean she have an appointment with doctor tomorrow to get the result but she do know one of the blood test was for an immune situation. She was trying to find she have all the blood test to get she was just trying to find them. They did 8 blood test (Further not clarified hence not captured in tab) and there is 164920AMA comprehensive + profile does that help. They are not getting better she would say they appear to be the same may be a little worse. The outcome for the events was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash macular, Ultrasound thyroid
Clinical narrative: migraine; Rash,pretty bad,only on upper torso from sternum up,my back,neck,to base of my scalp to skull, kind of freaky; It's more like red and purple bluish blotches everywhere and they are itchy; they are itchy; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0171, Expiry date was not reported), via an unspecified route of administration on 30Apr2021 (at the age of 53-years-old) in Arm Left as dose 2, single for COVID-19 immunization. Medical history included coeliac disease from 2012 to an unknown date and stated, I have to avoid Wheat, rye and barley. There is no medicine there is no treatment. narcolepsy from an unknown date and unknown if ongoing. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for narcolepsy, start and stop date were not reported. Patient received other products. The patient reviously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot Number: EW0158 and Expiry date was not reported), via an unspecified route of administration on 09Apr2021 as dose 1, single for COVID-19 immunization. On 07May2021, she broke out in this rash and it's pretty bad and only on the upper torso from the sternum up mostly her back her neck and all the way to the base of her scalp to her skull and is kind of freaky but was not red like hives and it was not red like the pictures she saw online was more like red and purple bluish blotches everywhere and they are itchy and she have tried Benadryl but it does not work and So, she had read that this is a side effect and she think it needs to be reported and it was not going away. On unspecified date patient had migraine. The patient underwent lab tests and procedures which included she actually did just have a bunch of blood test done blood work done on 05May2021 because it was like on Monday this past Monday she had an MRI with contrast unknown results, Ultrasound of the Thyroid unknown results. Consumer stated, she dont know the Lab test yet but she do know she mean she have an appointment with doctor tomorrow to get the result but she do know one of the blood test was for an immune situation. She was trying to find she have all the blood test to get she was just trying to find them. They did 8 blood test (Further not clarified hence not captured in tab) and there is 164920AMA comprehensive + profile does that help. They are not getting better she would say they appear to be the same may be a little worse. The outcome for the events was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acne, Dyskinesia, Pruritus
Clinical narrative: involuntary movements in her left fingers; itching all over her body; rash; This is a spontaneous report from a contactable consumer and pharmacist via medical information team. A 31-year-old female patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: FA6780, Expiration Date: Sep2021), via intramuscular route of administration, administered in deltoid left on 14Jul2021 at 11:00 (at the age of 31-year-old) as dose 1, 0.3 ml single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 15Jul2021, the patient experienced involuntary movements in her left fingers, itching all over her body, including her arms, neck and legs and rash. Patient is fine breathing; she had no problems there. Reporter wanted to know if the patient should get the second dose. Confirmed information with reporter as provided by transfer agent. Reporter clarifies that her first name is spelled. Reporter is also calling to see if patient should get the second dose of the covid vaccine. Outcome of the event itching all over her body was not recovered while outcome of other events was unknown. Follow-up attempts are completed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyskinesia, Pruritus, Rash
Clinical narrative: involuntary movements in her left fingers; itching all over her body; rash; This is a spontaneous report from a contactable consumer and pharmacist via medical information team. A 31-year-old female patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: FA6780, Expiration Date: Sep2021), via intramuscular route of administration, administered in deltoid left on 14Jul2021 at 11:00 (at the age of 31-year-old) as dose 1, 0.3 ml single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 15Jul2021, the patient experienced involuntary movements in her left fingers, itching all over her body, including her arms, neck and legs and rash. Patient is fine breathing; she had no problems there. Reporter wanted to know if the patient should get the second dose. Confirmed information with reporter as provided by transfer agent. Reporter clarifies that her first name is spelled. Reporter is also calling to see if patient should get the second dose of the covid vaccine. Outcome of the event itching all over her body was not recovered while outcome of other events was unknown. Follow-up attempts are completed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antibody test, Mobility decreased, Pancreatitis
Clinical narrative: two weeks after the J&J I was hospitalized with acute pancreatitis - 4 weeks recovery and then  battling RA.. on 9 weeks of steroids Both Drs say its related to covid and then getting the vaccine.   I do not drink, smoke , no health issues I was a healthy 55 year old. I am not a anti vax gal.. I took 7 people for the covid shot.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood test, Computerised tomogram, Pancreatitis acute, Rheumatoid arthritis
Clinical narrative: two weeks after the J&J I was hospitalized with acute pancreatitis - 4 weeks recovery and then  battling RA.. on 9 weeks of steroids Both Drs say its related to covid and then getting the vaccine.   I do not drink, smoke , no health issues I was a healthy 55 year old. I am not a anti vax gal.. I took 7 people for the covid shot.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan
Clinical narrative: two weeks after the J&J I was hospitalized with acute pancreatitis - 4 weeks recovery and then  battling RA.. on 9 weeks of steroids Both Drs say its related to covid and then getting the vaccine.   I do not drink, smoke , no health issues I was a healthy 55 year old. I am not a anti vax gal.. I took 7 people for the covid shot.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Disturbance in attention, Impaired work ability, Loss of personal independence in daily activities, Sleep disorder, Stress
Clinical narrative: lack of sleep; mood disturbance; experienced ringing in his head and his ears.It continued through his second dose and it continues through today; This is a spontaneous report from Medical information team ,a contactable consumer report for himself. A 56-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 2021 (age at vaccination was 56 years) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an 16Jun2021 (age at vaccination was 56 year) as DOSE 1, SINGLE for COVID-19 immunization. The patient experienced after his first dose on 16Jun2021 and 2 days after the first dose, the caller experienced ringing in his head and his ears. It continued through his second dose and it continues through today on 2021. He is experiencing lack of sleep and mood disturbance on 2021. The outcome of events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: lack of sleep; mood disturbance; experienced ringing in his head and his ears.It continued through his second dose and it continues through today; This is a spontaneous report from Medical information team ,a contactable consumer report for himself. A 56-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 2021 (age at vaccination was 56 years) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an 16Jun2021 (age at vaccination was 56 year) as DOSE 1, SINGLE for COVID-19 immunization. The patient experienced after his first dose on 16Jun2021 and 2 days after the first dose, the caller experienced ringing in his head and his ears. It continued through his second dose and it continues through today on 2021. He is experiencing lack of sleep and mood disturbance on 2021. The outcome of events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Affective disorder, Insomnia, Tinnitus
Clinical narrative: lack of sleep; mood disturbance; experienced ringing in his head and his ears.It continued through his second dose and it continues through today; This is a spontaneous report from Medical information team ,a contactable consumer report for himself. A 56-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 2021 (age at vaccination was 56 years) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an 16Jun2021 (age at vaccination was 56 year) as DOSE 1, SINGLE for COVID-19 immunization. The patient experienced after his first dose on 16Jun2021 and 2 days after the first dose, the caller experienced ringing in his head and his ears. It continued through his second dose and it continues through today on 2021. He is experiencing lack of sleep and mood disturbance on 2021. The outcome of events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anger, Disturbance in attention, Initial insomnia, Insomnia, Tinnitus
Clinical narrative: lack of sleep; mood disturbance; experienced ringing in his head and his ears.It continued through his second dose and it continues through today; This is a spontaneous report from Medical information team ,a contactable consumer report for himself. A 56-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 2021 (age at vaccination was 56 years) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an 16Jun2021 (age at vaccination was 56 year) as DOSE 1, SINGLE for COVID-19 immunization. The patient experienced after his first dose on 16Jun2021 and 2 days after the first dose, the caller experienced ringing in his head and his ears. It continued through his second dose and it continues through today on 2021. He is experiencing lack of sleep and mood disturbance on 2021. The outcome of events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Headache, Lymphadenopathy, Nausea
Clinical narrative: Intense headache pain; I am unable to carry out daily activities; As the days progressed I also became sensitive to light and nauseated; As the days progressed I also became sensitive to light and nauseated; swelling in the occipital lymph nodes and other lymph nodes in the neck; My skull is tender to the touch; Additionally I became short of breath (I am a runner who runs half marathons regularly).; intense pain and swelling in the occipital lymph nodes; swelling in the occipital lymph nodes and other lymph nodes in the neck; This is a spontaneous report from a contactable consumer. This 42-year-old female consumer reported for herself. A 42-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: FC3183, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 16Sep2021 at 15:15 (42-year-old at the time of vaccination) as dose 1, single for COVID-19 immunization at pharmacy or drug store. Medical history included MTHFR mutations (677 and 1298) (methylenetetrahydrofolate reductase gene mutation) and Sac (seasonal allergy). There were no concomitant medications. The patient did not receive any other vaccine in four weeks. The patient did not receive any other medications in two weeks. The patient did not have covid prior vaccination. The patient previously took tropicamide, quinolones, Vicodin, percocet [oxycodone hydrochloride; oxycodone terephthalate; paracetamol], codeine, sunscreen, Gadolinium, sucralose, aspartame, sac and experienced Known allergies. On 23Sep2021, the patient reported intense headache pain, unable to carry out daily activities, as the days progressed she also became sensitive to light and nauseated, her skull is tender to the touch, additionally she became short of breath (she was a runner who runs half marathons regularly), intense pain and swelling in the occipital lymph nodes and swelling in the occipital lymph nodes and other lymph nodes in the neck. Events leads to emergency room visit. Therapeutic measures were taken for the events with Reglan, Benadryl, and Toradol. The clinical outcome of the events was not recovered at the time of this report.  Follow-up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Headache, Loss of personal independence in daily activities, Lymph node pain, Lymphadenitis
Clinical narrative: Intense headache pain; I am unable to carry out daily activities; As the days progressed I also became sensitive to light and nauseated; As the days progressed I also became sensitive to light and nauseated; swelling in the occipital lymph nodes and other lymph nodes in the neck; My skull is tender to the touch; Additionally I became short of breath (I am a runner who runs half marathons regularly).; intense pain and swelling in the occipital lymph nodes; swelling in the occipital lymph nodes and other lymph nodes in the neck; This is a spontaneous report from a contactable consumer. This 42-year-old female consumer reported for herself. A 42-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: FC3183, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 16Sep2021 at 15:15 (42-year-old at the time of vaccination) as dose 1, single for COVID-19 immunization at pharmacy or drug store. Medical history included MTHFR mutations (677 and 1298) (methylenetetrahydrofolate reductase gene mutation) and Sac (seasonal allergy). There were no concomitant medications. The patient did not receive any other vaccine in four weeks. The patient did not receive any other medications in two weeks. The patient did not have covid prior vaccination. The patient previously took tropicamide, quinolones, Vicodin, percocet [oxycodone hydrochloride; oxycodone terephthalate; paracetamol], codeine, sunscreen, Gadolinium, sucralose, aspartame, sac and experienced Known allergies. On 23Sep2021, the patient reported intense headache pain, unable to carry out daily activities, as the days progressed she also became sensitive to light and nauseated, her skull is tender to the touch, additionally she became short of breath (she was a runner who runs half marathons regularly), intense pain and swelling in the occipital lymph nodes and swelling in the occipital lymph nodes and other lymph nodes in the neck. Events leads to emergency room visit. Therapeutic measures were taken for the events with Reglan, Benadryl, and Toradol. The clinical outcome of the events was not recovered at the time of this report.  Follow-up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Nausea, Photophobia, Tenderness
Clinical narrative: Intense headache pain; I am unable to carry out daily activities; As the days progressed I also became sensitive to light and nauseated; As the days progressed I also became sensitive to light and nauseated; swelling in the occipital lymph nodes and other lymph nodes in the neck; My skull is tender to the touch; Additionally I became short of breath (I am a runner who runs half marathons regularly).; intense pain and swelling in the occipital lymph nodes; swelling in the occipital lymph nodes and other lymph nodes in the neck; This is a spontaneous report from a contactable consumer. This 42-year-old female consumer reported for herself. A 42-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: FC3183, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 16Sep2021 at 15:15 (42-year-old at the time of vaccination) as dose 1, single for COVID-19 immunization at pharmacy or drug store. Medical history included MTHFR mutations (677 and 1298) (methylenetetrahydrofolate reductase gene mutation) and Sac (seasonal allergy). There were no concomitant medications. The patient did not receive any other vaccine in four weeks. The patient did not receive any other medications in two weeks. The patient did not have covid prior vaccination. The patient previously took tropicamide, quinolones, Vicodin, percocet [oxycodone hydrochloride; oxycodone terephthalate; paracetamol], codeine, sunscreen, Gadolinium, sucralose, aspartame, sac and experienced Known allergies. On 23Sep2021, the patient reported intense headache pain, unable to carry out daily activities, as the days progressed she also became sensitive to light and nauseated, her skull is tender to the touch, additionally she became short of breath (she was a runner who runs half marathons regularly), intense pain and swelling in the occipital lymph nodes and swelling in the occipital lymph nodes and other lymph nodes in the neck. Events leads to emergency room visit. Therapeutic measures were taken for the events with Reglan, Benadryl, and Toradol. The clinical outcome of the events was not recovered at the time of this report.  Follow-up attempts are completed. No further information is expected.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, COVID-19 pneumonia, Cardioversion, Ejection fraction decreased, Electrocardiogram ST segment elevation
Clinical narrative: pt transferred from outside facility after being diagnosed positive for COVID; was to receive monoclonal infusion but found to be hypoxic; pt experienced a seizure and lost pulse; CPR and defibrillator before ROSC; transferred then to UTMC; started on dexamethasone and steroids; renal failure worsened; developed pneumothorax; on ventilator; switched to comfort care and pt died in the hosp shortly afterwards
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Haemofiltration, Hepatic failure, Hypoxia, Mechanical ventilation
Clinical narrative: pt transferred from outside facility after being diagnosed positive for COVID; was to receive monoclonal infusion but found to be hypoxic; pt experienced a seizure and lost pulse; CPR and defibrillator before ROSC; transferred then to UTMC; started on dexamethasone and steroids; renal failure worsened; developed pneumothorax; on ventilator; switched to comfort care and pt died in the hosp shortly afterwards
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Pneumothorax, Pulse absent, Respiratory failure, Resuscitation
Clinical narrative: pt transferred from outside facility after being diagnosed positive for COVID; was to receive monoclonal infusion but found to be hypoxic; pt experienced a seizure and lost pulse; CPR and defibrillator before ROSC; transferred then to UTMC; started on dexamethasone and steroids; renal failure worsened; developed pneumothorax; on ventilator; switched to comfort care and pt died in the hosp shortly afterwards
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure like phenomena, Shock, Ventricular tachycardia, Vomiting
Clinical narrative: pt transferred from outside facility after being diagnosed positive for COVID; was to receive monoclonal infusion but found to be hypoxic; pt experienced a seizure and lost pulse; CPR and defibrillator before ROSC; transferred then to UTMC; started on dexamethasone and steroids; renal failure worsened; developed pneumothorax; on ventilator; switched to comfort care and pt died in the hosp shortly afterwards
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cardioversion, Death, Hypoxia, Mechanical ventilation
Clinical narrative: pt transferred from outside facility after being diagnosed positive for COVID; was to receive monoclonal infusion but found to be hypoxic; pt experienced a seizure and lost pulse; CPR and defibrillator before ROSC; transferred then to UTMC; started on dexamethasone and steroids; renal failure worsened; developed pneumothorax; on ventilator; switched to comfort care and pt died in the hosp shortly afterwards
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumothorax, Pulse absent, Renal failure, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: pt transferred from outside facility after being diagnosed positive for COVID; was to receive monoclonal infusion but found to be hypoxic; pt experienced a seizure and lost pulse; CPR and defibrillator before ROSC; transferred then to UTMC; started on dexamethasone and steroids; renal failure worsened; developed pneumothorax; on ventilator; switched to comfort care and pt died in the hosp shortly afterwards
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure
Clinical narrative: pt transferred from outside facility after being diagnosed positive for COVID; was to receive monoclonal infusion but found to be hypoxic; pt experienced a seizure and lost pulse; CPR and defibrillator before ROSC; transferred then to UTMC; started on dexamethasone and steroids; renal failure worsened; developed pneumothorax; on ventilator; switched to comfort care and pt died in the hosp shortly afterwards
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Laboratory test normal, Paraesthesia, Sensory disturbance
Clinical narrative: Pfizer Covid  vaccine on 1/23/21 and 2/14/21. On 2/20 she called in noting 1d of pins and needles and burning in skin all over, along with nausea, myalgias and muscle spasms;   Attributed possibly to increased use of nicotine gum.   She was seen by PMD on 2/23, and advised to stop nicotine gum, and use GBP.    She was seen again on 4/28 then 5/11 with mult complaints, including neck stiffness, numbness in bilat middle fingertips, stiffness/soreness of mult joints.  Also felt pins/needles at bilat soles and all over.  Pt felt symptom onset was related to her Covid vaccines, and had previously sought care. (She submitted article on 6/7, describing a case report that had some similarities with her case.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Arthralgia, Blood thyroid stimulating hormone, Full blood count, Hypoaesthesia
Clinical narrative: Pfizer Covid  vaccine on 1/23/21 and 2/14/21. On 2/20 she called in noting 1d of pins and needles and burning in skin all over, along with nausea, myalgias and muscle spasms;   Attributed possibly to increased use of nicotine gum.   She was seen by PMD on 2/23, and advised to stop nicotine gum, and use GBP.    She was seen again on 4/28 then 5/11 with mult complaints, including neck stiffness, numbness in bilat middle fingertips, stiffness/soreness of mult joints.  Also felt pins/needles at bilat soles and all over.  Pt felt symptom onset was related to her Covid vaccines, and had previously sought care. (She submitted article on 6/7, describing a case report that had some similarities with her case.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint stiffness, Laboratory test, Muscle spasms, Musculoskeletal stiffness, Myalgia
Clinical narrative: Pfizer Covid  vaccine on 1/23/21 and 2/14/21. On 2/20 she called in noting 1d of pins and needles and burning in skin all over, along with nausea, myalgias and muscle spasms;   Attributed possibly to increased use of nicotine gum.   She was seen by PMD on 2/23, and advised to stop nicotine gum, and use GBP.    She was seen again on 4/28 then 5/11 with mult complaints, including neck stiffness, numbness in bilat middle fingertips, stiffness/soreness of mult joints.  Also felt pins/needles at bilat soles and all over.  Pt felt symptom onset was related to her Covid vaccines, and had previously sought care. (She submitted article on 6/7, describing a case report that had some similarities with her case.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Paraesthesia, Red blood cell sedimentation rate normal, Skin burning sensation
Clinical narrative: Pfizer Covid  vaccine on 1/23/21 and 2/14/21. On 2/20 she called in noting 1d of pins and needles and burning in skin all over, along with nausea, myalgias and muscle spasms;   Attributed possibly to increased use of nicotine gum.   She was seen by PMD on 2/23, and advised to stop nicotine gum, and use GBP.    She was seen again on 4/28 then 5/11 with mult complaints, including neck stiffness, numbness in bilat middle fingertips, stiffness/soreness of mult joints.  Also felt pins/needles at bilat soles and all over.  Pt felt symptom onset was related to her Covid vaccines, and had previously sought care. (She submitted article on 6/7, describing a case report that had some similarities with her case.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Haematochezia, Heart rate increased, Lymphadenopathy, Neck pain
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vomiting
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaemia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chest tube insertion
Clinical narrative: pt brought to ED with increasing SOB; was seen @ urgent care facility day before coming to ED and diagnosed positive for COVID; given antibiotics and steroids; in ED was hypoxic with COVID pneumonia; condition worsened and pt required ICU care; later moved back to medical ward; developed GI bleed; O2 need increased; back to ICU; O2 sats dropped requiring intubation; ARF requiring CRRT; shock; comfort care measures; pt died in ICU
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax normal, Culture, Death, Deep vein thrombosis, Dyspnoea
Clinical narrative: pt brought to ED with increasing SOB; was seen @ urgent care facility day before coming to ED and diagnosed positive for COVID; given antibiotics and steroids; in ED was hypoxic with COVID pneumonia; condition worsened and pt required ICU care; later moved back to medical ward; developed GI bleed; O2 need increased; back to ICU; O2 sats dropped requiring intubation; ARF requiring CRRT; shock; comfort care measures; pt died in ICU
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Faeces discoloured, Gastrointestinal haemorrhage, Haemofiltration, Hypotension
Clinical narrative: pt brought to ED with increasing SOB; was seen @ urgent care facility day before coming to ED and diagnosed positive for COVID; given antibiotics and steroids; in ED was hypoxic with COVID pneumonia; condition worsened and pt required ICU care; later moved back to medical ward; developed GI bleed; O2 need increased; back to ICU; O2 sats dropped requiring intubation; ARF requiring CRRT; shock; comfort care measures; pt died in ICU
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Mechanical ventilation, Oxygen saturation decreased, Pneumothorax, Renal impairment
Clinical narrative: pt brought to ED with increasing SOB; was seen @ urgent care facility day before coming to ED and diagnosed positive for COVID; given antibiotics and steroids; in ED was hypoxic with COVID pneumonia; condition worsened and pt required ICU care; later moved back to medical ward; developed GI bleed; O2 need increased; back to ICU; O2 sats dropped requiring intubation; ARF requiring CRRT; shock; comfort care measures; pt died in ICU
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Shock, Transfusion, Ultrasound Doppler abnormal
Clinical narrative: pt brought to ED with increasing SOB; was seen @ urgent care facility day before coming to ED and diagnosed positive for COVID; given antibiotics and steroids; in ED was hypoxic with COVID pneumonia; condition worsened and pt required ICU care; later moved back to medical ward; developed GI bleed; O2 need increased; back to ICU; O2 sats dropped requiring intubation; ARF requiring CRRT; shock; comfort care measures; pt died in ICU
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Death, Dyspnoea
Clinical narrative: pt brought to ED with increasing SOB; was seen @ urgent care facility day before coming to ED and diagnosed positive for COVID; given antibiotics and steroids; in ED was hypoxic with COVID pneumonia; condition worsened and pt required ICU care; later moved back to medical ward; developed GI bleed; O2 need increased; back to ICU; O2 sats dropped requiring intubation; ARF requiring CRRT; shock; comfort care measures; pt died in ICU
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Gastrointestinal haemorrhage, Haemofiltration, Hypoxia, Intensive care
Clinical narrative: pt brought to ED with increasing SOB; was seen @ urgent care facility day before coming to ED and diagnosed positive for COVID; given antibiotics and steroids; in ED was hypoxic with COVID pneumonia; condition worsened and pt required ICU care; later moved back to medical ward; developed GI bleed; O2 need increased; back to ICU; O2 sats dropped requiring intubation; ARF requiring CRRT; shock; comfort care measures; pt died in ICU
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, SARS-CoV-2 test positive, Shock
Clinical narrative: pt brought to ED with increasing SOB; was seen @ urgent care facility day before coming to ED and diagnosed positive for COVID; given antibiotics and steroids; in ED was hypoxic with COVID pneumonia; condition worsened and pt required ICU care; later moved back to medical ward; developed GI bleed; O2 need increased; back to ICU; O2 sats dropped requiring intubation; ARF requiring CRRT; shock; comfort care measures; pt died in ICU
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Antifungal treatment, COVID-19 pneumonia, Cardiac arrest, Cardio-respiratory arrest, Central venous catheterisation
Clinical narrative: pt presents to ED with c/o dyspnea and dry cough; pt with intellectual disability; PMH:  HTN, hyperlipidemia, depression; placed on Vapotherm; dexamethasone; remdesivir; O2 sats declined requiring intubation; developed ARF requiring CRRT; experienced cardiac arrest; CPR administered and medications per protocol; pt died in the hospital
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Endotracheal intubation, Fungaemia, Haemofiltration, Oxygen saturation decreased
Clinical narrative: pt presents to ED with c/o dyspnea and dry cough; pt with intellectual disability; PMH:  HTN, hyperlipidemia, depression; placed on Vapotherm; dexamethasone; remdesivir; O2 sats declined requiring intubation; developed ARF requiring CRRT; experienced cardiac arrest; CPR administered and medications per protocol; pt died in the hospital
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal failure, Renal replacement therapy, Resuscitation, Vascular catheterisation
Clinical narrative: pt presents to ED with c/o dyspnea and dry cough; pt with intellectual disability; PMH:  HTN, hyperlipidemia, depression; placed on Vapotherm; dexamethasone; remdesivir; O2 sats declined requiring intubation; developed ARF requiring CRRT; experienced cardiac arrest; CPR administered and medications per protocol; pt died in the hospital
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Cardiac arrest, Cough, Death, Dyspnoea
Clinical narrative: pt presents to ED with c/o dyspnea and dry cough; pt with intellectual disability; PMH:  HTN, hyperlipidemia, depression; placed on Vapotherm; dexamethasone; remdesivir; O2 sats declined requiring intubation; developed ARF requiring CRRT; experienced cardiac arrest; CPR administered and medications per protocol; pt died in the hospital
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Haemofiltration, Oxygen saturation decreased, Resuscitation
Clinical narrative: pt presents to ED with c/o dyspnea and dry cough; pt with intellectual disability; PMH:  HTN, hyperlipidemia, depression; placed on Vapotherm; dexamethasone; remdesivir; O2 sats declined requiring intubation; developed ARF requiring CRRT; experienced cardiac arrest; CPR administered and medications per protocol; pt died in the hospital
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Blood cholesterol increased, Blood test abnormal, C-reactive protein normal, Chest X-ray abnormal
Clinical narrative: Migraines that disable me to work more than 2 days in a row.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Dysstasia, Epstein-Barr virus test positive
Clinical narrative: Migraines that disable me to work more than 2 days in a row.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Fatigue, Headache, Hyperhidrosis, Impaired work ability
Clinical narrative: Migraines that disable me to work more than 2 days in a row.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Infectious mononucleosis, Migraine, Mononuclear cell count abnormal, Myalgia, Nausea
Clinical narrative: Migraines that disable me to work more than 2 days in a row.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Otorrhoea, Pain in extremity, Paraesthesia, Pharyngeal erythema
Clinical narrative: Migraines that disable me to work more than 2 days in a row.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photopsia, Pyrexia, Sleep disorder, Throat tightness, Tinnitus
Clinical narrative: Migraines that disable me to work more than 2 days in a row.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo, Vision blurred, Vitamin D decreased, Vomiting
Clinical narrative: Migraines that disable me to work more than 2 days in a row.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Impaired work ability, Migraine
Clinical narrative: Migraines that disable me to work more than 2 days in a row.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Limb discomfort, Mobility decreased, Pain in extremity
Clinical narrative: SIRVA leading to frozen shoulder/rotator cuff injury
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Periarthritis, Rotator cuff syndrome, Shoulder injury related to vaccine administration
Clinical narrative: SIRVA leading to frozen shoulder/rotator cuff injury
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: RN administered the Moderna COVID booster in the low on the arm, not in the deltoid.
Age: 10.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: administration error: 10 year old given adult dose of vaccine
Age: 10.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: administration error: 10 year old given adult dose of vaccine
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administration error
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administration error
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product use issue
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 32.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 32.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 7.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness
Clinical narrative: Client fainted after receiving 1st dose of Pfizer vaccine. Vitals were stable. Client was given water, snacks and  observed for 15-minutes. EMS was notified immediately.  After EMS assessment client was discharged with parents and taken to Emergency Department for follow up.
Age: 7.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Syncope
Clinical narrative: Client fainted after receiving 1st dose of Pfizer vaccine. Vitals were stable. Client was given water, snacks and  observed for 15-minutes. EMS was notified immediately.  After EMS assessment client was discharged with parents and taken to Emergency Department for follow up.
Age: 7.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Erythema, Oropharyngeal pain
Clinical narrative: Client observed with flush (red) checks after receiving 1st dose of Pfizer vaccine.  EMS was called immediately.  Benadryl was given prior to EMS arrival. Client stated that he was having difficulty swallowing and his throat was hurting. Client had a history of Asthma. Client was alert upon arrival of EMS.  After assessment by EMS client  was taken to the hospital.
Age: 7.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Flushing, Oropharyngeal pain
Clinical narrative: Client observed with flush (red) checks after receiving 1st dose of Pfizer vaccine.  EMS was called immediately.  Benadryl was given prior to EMS arrival. Client stated that he was having difficulty swallowing and his throat was hurting. Client had a history of Asthma. Client was alert upon arrival of EMS.  After assessment by EMS client  was taken to the hospital.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Migraine
Clinical narrative: Migraine Friday; Headache started Thursday after shot, persistent headaches daily since vaccination; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2589) via an unspecified route of administration in the right arm on 03Nov2021 at 16:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30135BA) via an unspecified route of administration in the right arm on 07Oct2021 at 16:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 04Nov2021 at 12:00, the patient experienced headache which started after shot. On 05Nov2021, the patient experienced migraine and headaches was persistent daily since vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On an unknown date in 2021, the patient underwent SARS-COV-2 test (polymerase chain reaction (PCR)) and the result was negative. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events headache started after shot, migraine and persistent headaches daily since vaccination was not resolved at the time of report.